Number of single-base mutations in coding regions 6 9 13
Number of nonsynonymous single-base mutations 5 6 9
Single-base substitution rate (per site per year)
2.02 × 10 −8 9.92 × 10 −9 1.88 × 10 −8
Number of 1-to 10-bp indels 18 18 58 In the version of this article initially published, in Table 1 and its associated text, there was a calculation error in which the relative sizes of the case and control populations were set to be equal; because the size of the case population (15,767) was nearly double that of the control population (8,329), this resulted in erroneously inflated penetrance estimates. A simple definition of penetrance is used that is often applied in medical genetics-namely, the proportion of observed mutation carriers that are affected-to provide a metric that would be useful to clinical geneticists in a setting in which disease is heavily enriched, for example, in diagnosing children with developmental delay. That formulation is biased upwards with respect to population-level penetrance. Thus, in this corrigendum, an estimate more appropriate for population-level inference is provided assuming a general disease prevalence of 5.3% (Am. J. Hum. Genet. 42, 677-693, 1988 ) along with the more familiar odds ratio (OR) estimate. Importantly, all of these measures of penetrance are intrinsically limited by sampling error and imprecision in defining disease prevalence. We note that the mutation carrier counts, P values and other results in the original version of Table 1 are correct, and the key results and conclusions of the paper are unaffected. The error has been corrected in the HTML and PDF versions of the article.
C O R R I G E N D A
In contrast to the version of this article initially published, the authors find that there is now no evidence to support the association with esophageal squamous cell carcinoma susceptibility of rs17761864[A] at 17p13, rs6503659[A] at 17q21 or rs2847281 [C] at 18p11 in the original data, in two independent sets of cases and controls collected in other Chinese populations or in the joint analysis of three studies. The associations originally published appear to be due to inadequate control for population stratification. A reanalysis by the authors of these data resulted in corrected estimates for these SNPs in Beijing genome-wide association data (Nat. Genet. 46, [1001] [1002] [1003] [1004] [1005] [1006] 2014) . For more information on the role of the correction for population stratification in the differences between the previously published estimates for the three SNPs rs6503659, rs17761864 and rs2847281, see Supplementary Figure 8 and Supplementary Table 8 in the new publication (Nat. Genet. 46, 1001-1006, 2014) .
The error has been corrected in the HTML and PDF versions of the article. In addition, Supplementary Figure 1 and Supplementary Tables 1, 3, 5 and 7 have been corrected.
Corrigendum: Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54 In contrast to the version of this article initially published, the authors now find no evidence to support association with esophageal squamous cell carcinoma susceptibility for rs13042395 [T] at 20p13 in their original data, in two independent sets of cases and controls collected in other Chinese populations or in the joint analysis of these three studies.
The original signal at the C20orf54 locus (rs13042395) in the published Henan genome-wide association study (GWAS) was based on the scan of a total of 2,810 subjects (1,077 cases and 1,733 controls) with a per-allele odds ratio (OR) of 0.66 (95% confidence interval (CI) = 0.58-0.74; P =1.51 × 10 -11 ), and P < 5 × 10 -6 was reported for a genetically matched subset of 937 cases and 692 controls.
A new analysis by the authors (see Supplementary Table 8 in Nat. Genet. 46, 1001 Genet. 46, -1006 Genet. 46, , 2014 ) included a distinct genetically matched subset of the original genotypes (1,789 total subjects: 1,076 cases and 713 controls; OR = 0.80 (95% CI = 0.65-0.98); P = 0.03) and subjects scanned after publication of the initial Henan data (669 new subjects: 229 cases and 370 controls; OR = 1.06 (95% CI = 0.82-1.38); P = 0.63). The combination of the genetically matched and new subjects (n = 2,458 subjects in total: 1,375 cases and 1,083 controls) yielded OR = 0.88 (95% CI = 0.76-1.02; P = 9.12 × 10 -2 ).
Thus, the original Henan scan is the only result that showed a significant association for rs13042395. None of the three new analyses performed confirmed a significant association for rs13042395. Moreover, this SNP was not significant in the National Cancer Institute GWAS (OR = 0.95, 95% CI = 0.86-1.05; P = 3.04 × 10 -1 ), Beijing GWAS (OR = 1.07, 95% CI = 0.93-1.23; P = 3.34 × 10 -1 ) or combined data (OR = 0.96, 95% CI = 0.90-1.03; P = 3.02 × 10 -1 ; see Supplementary Table 8 in Nat. Genet. 46, 1001 Genet. 46, -1006 Genet. 46, , 2014 .
In summary, the published association for rs13042395 did not replicate in additional analyses of data from Henan. Nor did it replicate in a GWAS from a similar high-risk population (National Cancer Institute) or in a GWAS from a low-risk population (Beijing). Thus, the original finding was likely the result of inadequate control for population stratification using the genetically unmatched subjects or, less likely, could have been due to chance alone.
The error has been corrected in the HTML and PDF versions of the article. In addition, Supplementary Figures 1-4 
